We showed that whilst CA19-9, PKM2, CYFRA21.1 and MUC5AC could discriminate CCA cases independently of total bilirubin, the sensitivities of the biomarker panels at fixed specificity were reduced in high bilirubin cases, particularly those panels including CYFRA21.1. Here, PKM is linked to cholangiocarcinoma.